Marijuana legalization advocates are intensifying their efforts to raise awareness across the state as lawmakers prepare for a possible vote this spring. Tuesday, the New Jersey Cannabusiness Association held what it called “an educational seminar” for more than 200 people from local, state and county governments, as well as law enforcement. There were medical experts who talked about the plant’s potential to put a dent in the opioid crisis, if big Pharma and insurance companies would get out of the way.
“They are not paying attention,” charged Dr. Sanjay Gupta, president of the American Pain Association. “They will approve a much stronger opioid than a weaker opioid. They will approve other modalities, which are leading to addiction, but they will not approve alternatives to opioids, so I think that’s one of the major problems we are facing.”
For full article, click here.
